Wang, Bei
Ling, Dandan
Li, Lihong
Zhang, Jun
Xu, Jianghui
Article History
Received: 11 December 2023
Accepted: 8 February 2024
First Online: 21 February 2024
Declarations
:
: The authors declare no competing interests.
: The present study was approved by the Ethics Committee of Fudan University Shanghai Cancer (FUSCC) (No. IRB2105235-6), China. All methods in the study were carried out in accordance with relevant guidelines and regulations of the Declaration of Helsinki. The patients have signed informed consent in the study.
: Not applicable.